{"gene":"POU2AF1","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1995,"finding":"OBF-1/OCA-B (POU2AF1) is a B cell-specific transcriptional coactivator with no intrinsic DNA-binding activity that physically associates with the POU domains of Oct-1 and Oct-2 (but not Oct-4 or Oct-6) and stimulates immunoglobulin promoter activity in an octamer site-dependent manner.","method":"Yeast two-hybrid screen, biochemical co-association assays, HeLa cell transcription reporter assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — identified by genetic screen then confirmed by biochemical binding and functional transcription assay; independently replicated by two concurrent labs (PMID:7859290 and PMID:7623806)","pmids":["7859290","7623806"],"is_preprint":false},{"year":1995,"finding":"A single OCA-B polypeptide (34–35 kDa) is sufficient for B cell-specific activation of Ig promoters; POU domains of Oct-1 or Oct-2 are sufficient for OCA-B interaction, but an additional Oct activation domain is also required for full functional synergy with OCA-B. OCA-B additionally requires USA-derived general cofactors (including PC2 and PC4) for optimal activity in a reconstituted cell-free system, and directly interacts with PC4.","method":"Recombinant protein biochemical reconstitution, in vitro transcription assay, cofactor fractionation and add-back","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted with recombinant protein in cell-free system, multiple orthogonal biochemical methods in one rigorous study","pmids":["7623806","9632764"],"is_preprint":false},{"year":1996,"finding":"OBF-1/OCA-B-deficient mice (generated by gene targeting) show severe defects in antigen-dependent B cell responses and completely fail to develop germinal centers after immunization, while immunoglobulin gene rearrangement/transcription and early B cell development are largely unaffected.","method":"Gene targeting / knockout mouse, immunization, histology, serum Ig measurement","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — independently replicated in three concurrent knockout mouse studies from different labs","pmids":["8849727","8849728","8977324"],"is_preprint":false},{"year":1996,"finding":"OCA-B binds DNA directly in the major groove between the two POU subdomains, requiring both an adenine at position 5 of the octamer element and contact with the POU domain; an amino-terminal fragment of OCA-B can bind the octamer site independently of a POU domain with the same sequence specificity, suggesting a POU-dependent conformational change exposes the OCA-B N-terminus.","method":"Electrophoretic mobility shift assay (EMSA), DNA binding assays with truncation mutants","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct DNA binding established biochemically with multiple truncation mutants, single lab","pmids":["8769650"],"is_preprint":false},{"year":1996,"finding":"Bob1/OBF-1 forms ternary complexes with Oct-1 or Oct-2 bound to DNA in a sequence-selective manner; the N-terminal region (amino acids 26–32) of Bob1 contacts the POU-specific subdomain of Oct-1/Oct-2, and ternary complex formation occurs only on a subset of octamer sequences, conferring differential promoter activation.","method":"Mutational analysis, EMSA ternary complex assays, transcription reporter assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with EMSA and functional transcription assay in one study; findings consistent with multiple other structural and biochemical studies","pmids":["8654375"],"is_preprint":false},{"year":1998,"finding":"OCA-B makes selective contacts with both the POU-specific domain (residues L6, E7) and the POU homeodomain (residues K155, I159) of Oct-1, acting as a molecular clamp that holds together the two moieties of the POU domain on DNA; in vivo, OCA-B can recruit two artificially separated POU domain halves to a promoter to achieve transactivation.","method":"Oct-1/Pit-1 POU domain chimeras, alanine-scanning mutagenesis, methylation interference, phosphorothioate EMSA, in vivo transactivation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biochemical methods plus in vivo functional validation, single lab","pmids":["9819426"],"is_preprint":false},{"year":1997,"finding":"OCA-B is a functional analog of VP16 in that it provides a transcriptional activation domain and stabilizes Oct-1 on the octamer sequence, but contacts a different surface of the Oct-1 POU domain (both POU-specific and POU homeodomain plus center of octamer DNA); OCA-B and VP16 can bind the Oct-1 POU domain simultaneously.","method":"In vitro binding assays, transcription reporter assays, competition binding experiments","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical and functional assays, single lab","pmids":["9372961"],"is_preprint":false},{"year":1998,"finding":"OBF-1 interacts with the general transcription factors TBP and TFIIB in the absence of DNA, in addition to its interactions with Oct-1/Oct-2 POU domains. OBF-1 activates promoter octamer sites but not enhancer octamer sites.","method":"In vitro protein interaction assay, transcription reporter assay","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-interaction assay plus functional reporter, single lab","pmids":["8657574"],"is_preprint":false},{"year":1999,"finding":"Crystal structure (3.2 Å) of OCA-B peptide/Oct-1 POU domain/octamer DNA ternary complex shows: OCA-B peptide binds in the major groove near the center of the octamer, forming hydrogen bonds with adenine at position 5; an alpha-helix of OCA-B binds a hydrophobic pocket on the POU-specific domain; both peptide-DNA and peptide-protein contacts provide structural specificity.","method":"X-ray crystallography (3.2 Å resolution)","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure at 3.2 Å, consistent with prior biochemical studies, directly establishes molecular contacts","pmids":["10541551"],"is_preprint":false},{"year":1999,"finding":"Bob1 binds specifically as a monomer to the complex of Oct-1 POU domain and Igκ promoter DNA, but binds weakly to either component alone, indicating both are required for avid binding; ternary complex formation requires defined DNA sequence and is sensitive to single base-pair changes; Bob1 undergoes partial folding upon ternary complex formation (induced folding).","method":"Biophysical characterization (gel filtration, calorimetry, circular dichroism, ITC)","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biophysical methods establishing mechanism of ternary complex assembly, single lab","pmids":["10329190"],"is_preprint":false},{"year":2000,"finding":"The POU dimer assembled on the PORE sequence (ATTTGAAATGCAAAT) can recruit OBF-1, whereas POU dimers formed on the MORE sequence cannot interact with OBF-1 because the same Oct-1 residues that form the MORE dimerization interface are also used for OBF-1/Oct-1 interactions on the PORE. Thus specific POU dimer configurations differentially recruit OBF-1.","method":"EMSA ternary complex formation assays, dimerization interface mutagenesis, transcription reporter assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with EMSA and functional transcription assay, single lab but rigorous mechanistic resolution","pmids":["11136971"],"is_preprint":false},{"year":2001,"finding":"The RING finger E3 ubiquitin ligase Siah-1 directly interacts with OBF-1 (via Siah-1 C-terminus and OBF-1 N-terminus, partly distinct from the Oct/DNA interaction surface); this interaction leads to downregulation of OBF-1 protein level (not mRNA) and reduction in octamer-dependent transcription; inhibition of the ubiquitin-proteasome pathway in B cells elevates OBF-1 protein; OBF-1 protein dramatically increases in primary activated B cells upon immunization without change in mRNA.","method":"Yeast two-hybrid, co-immunoprecipitation, protein level analysis, proteasome inhibitor treatment, in vivo B cell activation experiments","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal interaction mapping, proteasome inhibitor experiments, and in vivo validation, single lab, multiple orthogonal methods","pmids":["11483517"],"is_preprint":false},{"year":2001,"finding":"Mice whose lymphoid compartment is reconstituted with cells lacking both Oct-2 and OBF-1 still develop B cells to the IgM+ stage with essentially unaffected Ig gene transcription, implying that ubiquitous Oct-1 can substitute for Oct-2 and OBF-1 in basic Ig transcription; both factors are essential for germinal center formation, with OBF-1 being more important for IgG production.","method":"Genetic epistasis via compound knockout mice, bone marrow reconstitution, flow cytometry, Ig transcription analysis","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-knockout epistasis with defined B cell phenotype, replicated across multiple labs","pmids":["11135581"],"is_preprint":false},{"year":2001,"finding":"OCA-B has a novel membrane-associated isoform (p35/p40) that is myristoylated in vivo; myristoylation leads to localization of p35 to membrane compartments, distinct from the nuclear p34 isoform, suggesting a non-transcriptional signaling function in late B cell development.","method":"Biochemical purification, metabolic labeling for myristoylation, subcellular fractionation, isoform characterization","journal":"Immunity","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct biochemical demonstration of myristoylation and membrane localization, single lab","pmids":["11239448"],"is_preprint":false},{"year":2000,"finding":"TAF(II)105 (a B cell-enriched TFIID subunit) specifically interacts with the C-terminal activation domain of OCA-B and is required for OCA-B-dependent octamer-mediated transcription in B cells; this interaction links TFIID to B cell-specific transcription.","method":"In vitro binding assays, dominant-negative overexpression, antibody inhibition of transcription, reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction mapping, functional inhibition, reporter assay; single lab","pmids":["10828057"],"is_preprint":false},{"year":2003,"finding":"OBF1 stabilizes POU dimer–DNA interactions on PORE-type sequences and overrides Oct1 interface mutations that would otherwise abolish PORE-mediated dimerization; the PORE-type Oct1/Oct2 dimer (not the monomer) is the primary target of OBF1, and OBF1 alleviates DNA sequence requirements of the Oct1 dimer on PORE-related sequences.","method":"EMSA, in vitro ternary complex formation with mutant POU proteins, transcription reporter assays","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical assays clarifying dimer vs monomer targeting, single lab","pmids":["12727885"],"is_preprint":false},{"year":2006,"finding":"OCA-B directly interacts with the tyrosine kinase SYK in the cytoplasm and directly regulates SYK protein stability; this non-transcriptional function is required for pre-BCR and BCR signaling at multiple stages of B cell development (pre-B1 to pre-B2 transition).","method":"Co-immunoprecipitation, subcellular fractionation, SYK stability assays, genetic rescue experiments","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP of endogenous proteins, stability assays, cytoplasmic localization, defined developmental phenotype; single lab but rigorous multi-method study","pmids":["16713566"],"is_preprint":false},{"year":2006,"finding":"OCA-B directly interacts with galectin-1 (and related galectins) via its N-terminal domain; in OCA-B-deficient B cells, increased galectin-1 expression and cell surface association correlates with reduced CD45 phosphatase activity and negative regulation of B cell proliferation upon BCR stimulation.","method":"Co-immunoprecipitation (in vivo and in vitro), domain mapping, CD45 phosphatase activity assay, B cell proliferation assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP and in vitro binding with domain mapping, single lab","pmids":["16565088"],"is_preprint":false},{"year":2006,"finding":"The Ets transcription factor Spi-B is a direct transcriptional target of OBF-1; OBF-1 binds to the Spi-B promoter and OBF-1 deficiency reduces Spi-B expression; transgenic T cell expression of OBF-1 reveals Spi-B as a critical downstream mediator linking OBF-1 to B cell receptor signaling and germinal center formation.","method":"Transgenic mouse overexpression, microarray analysis, chromatin immunoprecipitation (ChIP), knockout mouse experiments","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP plus microarray plus genetic gain- and loss-of-function in vivo, single lab","pmids":["16861304"],"is_preprint":false},{"year":2007,"finding":"XBP-1(S) directly binds to the OBF-1/BOB-1/OCA-B promoter (at a UPR element conserved in mouse and human) in plasmacytoma cells and in primary B cells, both during plasma cell differentiation and in response to UPR activation, identifying OCA-B as a direct transcriptional target of XBP-1(S).","method":"Chromatin immunoprecipitation (ChIP), gel shift assay (EMSA), shRNA knockdown, promoter-reporter assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus EMSA plus shRNA with functional readout, single lab","pmids":["17709512"],"is_preprint":false},{"year":2007,"finding":"POU2AF1/OCA-B directly binds to an octamer site within the 5' regulatory region of TNFRSF17 (BCMA) and transactivates its expression; knockdown of POU2AF1 by siRNA inhibits multiple myeloma cell growth, while ectopic expression promotes it.","method":"siRNA knockdown, ectopic overexpression, ChIP, promoter reporter assay, cell growth assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct binding plus functional siRNA/overexpression with cellular phenotype, single lab","pmids":["17621271"],"is_preprint":false},{"year":2011,"finding":"OCA-B directly interacts with transcription factor TFII-I; OCA-B bound to the Igh 3' enhancer interacts with promoter-bound TFII-I to mediate promoter-enhancer looping (in cis and trans), and OCA-B also relieves HDAC3-mediated Igh promoter repression by competing with HDAC3 for binding to TFII-I.","method":"Co-immunoprecipitation, chromatin conformation capture (3C), ChIP, in vitro binding assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct interaction by co-IP and in vitro binding, chromosome conformation capture for looping, competition assay for HDAC3 displacement; multiple orthogonal methods, single lab","pmids":["21549311"],"is_preprint":false},{"year":2013,"finding":"Bob1 protein degradation is proteasome-mediated but does not require ubiquitination of Bob1; a C-terminal acidic region of Bob1 regulates the activity of degron signals elsewhere in the protein; tyrosine phosphorylation-mimetic mutations that make the C terminus more acidic stabilize the Bob1 protein, suggesting signaling pathways regulate Bob1 stability through this mechanism. Expression of a stable Bob1 mutant in B cells suppresses cell proliferation and induces differentiation markers.","method":"Fluorescent protein reporter degradation assay, proteasome inhibitor treatment, mutagenesis (phosphomimetic substitutions), ubiquitination assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional mutagenesis experiments and proteasome inhibitors, single lab","pmids":["24061476"],"is_preprint":false},{"year":2015,"finding":"OCA-B is required for CD4+ T cell memory: it is needed to maintain a poised (H3K4me1/H3K4me3) chromatin state at the Il2 locus in resting previously stimulated CD4+ T cells, and recruits the histone lysine demethylase Jmjd1a to target loci including Il2, Ifng, and Zbtb32, enabling rapid gene reactivation upon antigen re-encounter.","method":"Conditional knockout mice, ChIP-seq, co-immunoprecipitation (OCA-B with Jmjd1a), flow cytometry, in vivo viral infection model","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-seq, co-IP of endogenous proteins, conditional KO with defined memory phenotype, and mechanistic histone demethylase recruitment; multiple orthogonal methods","pmids":["26481684"],"is_preprint":false},{"year":2016,"finding":"Bob1 (OBF1) directly binds to and transactivates the Bcl6 and Btla promoters in CD4+ T cells together with Oct1/Oct2; mixed bone marrow chimeras demonstrated this is a T cell-intrinsic requirement for Bcl6 expression and Tfh cell development/pool size.","method":"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, mixed bone marrow chimeras, flow cytometry","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter plus in vivo chimera, single lab","pmids":["26957522"],"is_preprint":false},{"year":2019,"finding":"Bob1 interacts with RORγt (via the ligand-binding domain of RORγt) and enhances RORγt-mediated IL-17A transcription in Th17 cells; this enhancement requires the ability of Bob1 to form a DNA-Oct1-Bob1 ternary complex.","method":"Co-immunoprecipitation, reporter gene assay, Bob1 knockout mice (EAE model), domain mapping","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus functional reporter plus in vivo KO, single lab","pmids":["31103264"],"is_preprint":false},{"year":2019,"finding":"MTA2/NuRD complex and OCA-B synergistically repress Igll1 and VpreB1 at the pre-B cell stage; MTA2 deficiency leads to increased H3K27 acetylation at these promoters; OCA-B and MTA2 cooperate to regulate the pre-B to immature B cell transition.","method":"Compound knockout mouse genetics, ChIP (H3K27ac), gene expression profiling","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — compound genetic epistasis plus ChIP, single lab","pmids":["31291582"],"is_preprint":false},{"year":2021,"finding":"OBF1, OCT1, and OCT2 colocalize genome-wide (ChIP-seq) at promoters and enhancers of GC regulatory genes (BCL6, IRF4, etc.) in GC B cells; OBF1 downregulation (shRNA) disrupts the GC transcriptional program: GC maintenance genes (e.g., BCL6) are downregulated and GC exit genes (e.g., IRF4) are upregulated; ectopic BCL6 does not rescue proliferation of OBF1-depleted GC lymphoma cells unless IRF4 is also depleted.","method":"ChIP-seq, shRNA knockdown, ectopic expression, cell proliferation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq plus functional shRNA with epistasis experiment, single lab, multiple orthogonal methods","pmids":["33512466"],"is_preprint":false},{"year":2021,"finding":"T cell-specific conditional OCA-B knockout protects NOD mice from spontaneous autoimmune diabetes; rationally designed membrane-penetrating OCA-B peptide inhibitors normalized blood glucose and reduced T cell infiltration and proinflammatory cytokine expression in newly diabetic NOD mice, demonstrating pharmacologic inhibitability.","method":"Conditional knockout mouse (Cre-lox), peptide inhibitor pharmacology, histology, flow cytometry, cytokine measurement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined phenotype plus peptide inhibitor with functional readout, single lab, multiple approaches","pmids":["33295943"],"is_preprint":false},{"year":2021,"finding":"POU2AF1/OCA-B promotes MSC adipogenesis by inhibiting nuclear translocation and mRNA expression of HDAC1; overexpression of OCA-B promoted spontaneous adipogenesis, and co-transfection with HDAC1 partially reversed this effect.","method":"Adenoviral overexpression, siRNA knockdown, Oil-red O staining, Western blot, subcellular fractionation","journal":"Adipocyte","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single cell type, no direct binding demonstrated between OCA-B and HDAC1","pmids":["33949290"],"is_preprint":false},{"year":2024,"finding":"OCA-B expression is sufficient to improve CD4+ T cell antiviral memory recall responses; high endogenous OCA-B expression early in viral infection prospectively identifies memory precursor cells with increased survival and memory recall potential (using OCA-B mCherry reporter mouse).","method":"Ectopic overexpression in vivo (retroviral), OCA-B-mCherry reporter mouse, viral infection model, flow cytometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function in vivo plus reporter mouse, single lab, multiple functional assays","pmids":["38386711"],"is_preprint":false},{"year":2024,"finding":"EMSA-SELEX-Seq analysis reaffirms that BOB1 selectively engages the dimer configuration of OCT1/2, but clarifies that monomeric OCT1/2 assembled on the classical octamer ATGCAAAT and related motifs are also primary BOB1 targets; BOB1 imposes a specific DNA sequence preference on OCT1/2 in monomeric configuration.","method":"EMSA-SELEX-Seq (in vitro selection combined with sequencing)","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous in vitro binding/selection method, but single study refining/contradicting prior model","pmids":["38254723"],"is_preprint":false},{"year":2025,"finding":"OCA-B is required for pathogenic maturation of stem-like CD4+ T cells in EAE; T cell-intrinsic OCA-B loss nearly eliminates CNS infiltration and clinical disease upon autoantigen re-encounter; OCA-B promotes Tcf7, Slamf6, and Sell expression in proliferating CNS T cell populations during remission, and its loss at relapse results in accumulation of immunomodulatory (Ccr9+Bach2+) CD4+ T cells.","method":"T cell-specific conditional knockout (Cre-lox), relapsing-remitting EAE model, flow cytometry, gene expression analysis","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined in vivo phenotype, single lab","pmids":["40299553"],"is_preprint":false},{"year":2025,"finding":"Pou2af1/OCA-B in Tfh cells promotes optimal CXCR5 expression and GC migration through a Bhlhe40-Pou2af1 axis: Pou2af1 upregulates CXCR5 but not Bcl6, while Bhlhe40 represses Pou2af1 expression; this circuit operates independently of the Bcl6-Blimp1 fate-determination axis.","method":"Conditional knockout, RNA-seq of antigen-specific Tfh cells, flow cytometry, CXCR5 expression analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with RNA-seq and defined phenotype, single lab","pmids":["41134666"],"is_preprint":false},{"year":2025,"finding":"OCA-B restricts Th2 differentiation: proximity labeling shows OCA-B indirectly associates with GATA3; ChIP-seq reveals co-enrichment of GATA3 and Oct1 (OCA-B partner) at the Th2 locus control region (Il4, Il13, Il5, Gata3, Irf4); recombinant protein DNA binding and reporter assays are consistent with OCA-B restraining transcription at these loci.","method":"Proximity labeling (BioID), ChIP-seq, recombinant protein DNA binding assay, reporter assay, in vivo papain allergy model with T cell-specific OCA-B deletion","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods including ChIP-seq, biochemical binding, and in vivo conditional KO, single lab","pmids":["40364837"],"is_preprint":false},{"year":2026,"finding":"OCA-B is recruited to target genes through primary interactions with DNA-binding transcription factors OCT1/OCT2 as well as secondary interactions with MEF2B; its transcriptional activation involves interactions with the Mediator coactivator complex; GC B cell-specific inactivation of Oca-B is sufficient to cause GC defects.","method":"Mechanistic review citing primary experimental data; GC B cell-specific conditional inactivation","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — review citing primary experimental evidence for MEF2B interaction and Mediator complex interaction; conditional GC B cell KO","pmids":["41939912"],"is_preprint":false}],"current_model":"POU2AF1/OCA-B/OBF-1/Bob1 is a lymphoid-enriched transcriptional coactivator that lacks intrinsic DNA-binding activity but is recruited to octamer-containing promoters and enhancers by forming a ternary complex with DNA-bound Oct-1 or Oct-2 (contacting both POU-specific and POU homeodomain subdomains as well as the DNA major groove); it activates Ig and other B cell target genes by engaging general cofactors (TBP, TFIIB, PC4, PC2, TAF(II)105) and the Mediator complex, mediates Igh enhancer-promoter looping via direct interaction with TFII-I, and has its protein level controlled by Siah-1/proteasome-mediated degradation regulated by a C-terminal acidic degron; beyond its nuclear transcriptional role, a myristoylated membrane-bound isoform (p35) directly interacts with the tyrosine kinase SYK in the cytoplasm to regulate BCR/pre-BCR signaling and B cell survival; in T cells, OCA-B recruits the histone demethylase Jmjd1a to maintain chromatin poising at memory-associated loci (Il2, Ifng), promotes Tfh development by transactivating Bcl6 and CXCR5, and drives pathogenic autoreactive CD4+ T cell responses, making it an essential regulator of germinal center formation, humoral immunity, and multiple autoimmune processes."},"narrative":{"mechanistic_narrative":"POU2AF1 (OCA-B/OBF-1/Bob1) is a lymphoid-restricted transcriptional coactivator that lacks intrinsic sequence-specific DNA-binding activity and instead acts by docking onto DNA-bound octamer-binding factors Oct-1 and Oct-2 to drive immunoglobulin and other B-cell target genes [PMID:7859290, PMID:7623806, PMID:9632764]. Structural and biophysical work shows it assembles a ternary complex in which an OCA-B peptide inserts into the octamer major groove, contacting an adenine at position 5, while an OCA-B α-helix engages a hydrophobic pocket on the POU-specific subdomain; OCA-B further clamps the POU-specific and POU homeodomain halves together on DNA and undergoes induced folding upon complex assembly [PMID:9819426, PMID:10541551, PMID:10329190]. Octamer recognition is configuration-selective: OCA-B is stabilized on monomeric octamer sites and on PORE-type Oct dimers but is excluded from MORE-type dimers whose interface overlaps the OCA-B contact surface [PMID:11136971, PMID:38254723]. Once recruited, OCA-B transactivates by engaging the general transcription machinery and B-cell-enriched cofactors—TBP and TFIIB, the USA cofactors PC2/PC4, and the TFIID subunit TAF(II)105—and mediates Igh enhancer-promoter looping through direct interaction with TFII-I while displacing repressive HDAC3 [PMID:7623806, PMID:9632764, PMID:8657574, PMID:10828057, PMID:21549311]. In vivo, OCA-B is dispensable for early B-cell development and basal Ig transcription but is essential for antigen-dependent germinal center formation and the germinal-center transcriptional program (BCL6 up, IRF4 restrained) [PMID:8849727, PMID:8849728, PMID:8977324, PMID:11135581, PMID:33512466]. Its abundance is set post-translationally by Siah-1/proteasome-dependent turnover acting through a C-terminal acidic degron, linking signaling to coactivator dosage [PMID:11483517, PMID:24061476]. Beyond the nucleus, a myristoylated membrane isoform directly binds the tyrosine kinase SYK to stabilize it and support pre-BCR/BCR signaling during B-cell development [PMID:11239448, PMID:16713566]. In T cells, OCA-B partners with Oct1/Oct2 and recruits the demethylase Jmjd1a to poise memory loci (Il2, Ifng), drives Tfh development via Bcl6/CXCR5, and licenses pathogenic autoreactive CD4+ responses, establishing it as a tractable target whose inhibition protects against autoimmune diabetes and EAE [PMID:26481684, PMID:26957522, PMID:33295943, PMID:40299553, PMID:41134666].","teleology":[{"year":1995,"claim":"Established the founding mechanistic principle: OCA-B is a B-cell-specific coactivator with no intrinsic DNA binding that works by associating with the POU domains of Oct-1/Oct-2 to activate octamer-dependent Ig transcription.","evidence":"Yeast two-hybrid screen, co-association assays, and reconstituted in vitro transcription with recombinant protein and cofactor add-back","pmids":["7859290","7623806","9632764"],"confidence":"High","gaps":["Did not define the atomic contacts with the POU domain","Required general cofactors (PC2/PC4) identified but mechanism of their contribution unresolved"]},{"year":1996,"claim":"Genetic loss-of-function pinned OCA-B's physiological role to antigen-dependent humoral immunity rather than basal Ig expression, by showing knockouts fail to form germinal centers while early B development and Ig rearrangement are intact.","evidence":"Three concurrent gene-targeted knockout mouse studies with immunization and histology","pmids":["8849727","8849728","8977324"],"confidence":"High","gaps":["Did not explain why basal Ig transcription is spared","Downstream target genes mediating the GC defect not identified"]},{"year":1996,"claim":"Resolved how a DNA-binding-deficient coactivator gains octamer selectivity, showing OCA-B contacts the DNA major groove (requiring adenine at octamer position 5) and the POU-specific subdomain, forming ternary complexes only on a subset of octamer sequences.","evidence":"EMSA ternary complex assays, truncation/point mutagenesis, transcription reporters","pmids":["8769650","8654375"],"confidence":"High","gaps":["Atomic-resolution geometry not yet determined","Functional consequence of sequence-selective recruitment in vivo unaddressed"]},{"year":1998,"claim":"Defined the dual-contact 'molecular clamp' mechanism in which OCA-B simultaneously grips the POU-specific and POU homeodomain subdomains and bridges separated POU halves on a promoter.","evidence":"POU domain chimeras, alanine scanning, methylation/phosphorothioate interference, in vivo transactivation","pmids":["9819426","8657574"],"confidence":"High","gaps":["Connection to general transcription machinery recruitment incompletely mapped"]},{"year":1999,"claim":"Provided the structural and thermodynamic basis of complex assembly, visualizing OCA-B peptide-DNA and peptide-protein contacts and demonstrating cooperative, induced-folding ternary binding.","evidence":"3.2 Å X-ray crystal structure plus gel filtration, calorimetry, CD, ITC","pmids":["10541551","10329190"],"confidence":"High","gaps":["Crystallized peptide rather than full-length protein","Structure of OCA-B engaging Oct dimers not captured"]},{"year":2003,"claim":"Clarified which Oct configuration OCA-B preferentially targets, showing OCA-B stabilizes PORE-type Oct1/Oct2 dimers and overrides interface mutations, but cannot engage MORE-type dimers due to overlapping surfaces.","evidence":"EMSA ternary complex with mutant POU proteins and transcription reporters","pmids":["11136971","12727885"],"confidence":"High","gaps":["Genome-wide proportion of monomer vs dimer targets unresolved at the time","Promoter-context determinants of dimer formation incompletely defined"]},{"year":2024,"claim":"Refined the DNA recognition model using unbiased selection, confirming dimer engagement but re-establishing monomeric Oct1/2 on classical octamers as primary OCA-B targets and showing OCA-B imposes its own sequence preference.","evidence":"EMSA-SELEX-Seq in vitro selection","pmids":["38254723"],"confidence":"Medium","gaps":["Single study refining the prior dimer-centric model","In vivo correlation with occupancy not addressed in the same work"]},{"year":2000,"claim":"Connected OCA-B to the basal transcription apparatus by identifying the B-cell-enriched TFIID subunit TAF(II)105 as a C-terminal activation-domain partner required for octamer transcription.","evidence":"In vitro binding, dominant-negative and antibody inhibition, reporter assays","pmids":["10828057"],"confidence":"Medium","gaps":["Stoichiometry within TFIID not defined","Relative contribution of TAF(II)105 versus TBP/TFIIB unclear"]},{"year":2001,"claim":"Showed OCA-B abundance is controlled post-translationally, identifying Siah-1-mediated proteasomal degradation as a switch that rises sharply upon B-cell activation independent of mRNA.","evidence":"Yeast two-hybrid, reciprocal co-IP, proteasome inhibitor and in vivo activation experiments","pmids":["11483517"],"confidence":"High","gaps":["Whether Siah-1 directly ubiquitinates OCA-B not settled here","Upstream signals controlling Siah-1 engagement unknown"]},{"year":2013,"claim":"Refined the degradation mechanism, showing proteasomal turnover proceeds without OCA-B ubiquitination and is gated by a C-terminal acidic degron whose acidity (mimicking tyrosine phosphorylation) stabilizes the protein.","evidence":"Fluorescent reporter degradation assays, phosphomimetic mutagenesis, proteasome inhibitors, ubiquitination assay","pmids":["24061476"],"confidence":"Medium","gaps":["Identity of the kinase generating the stabilizing modification not established","How a ubiquitin-independent substrate is delivered to the proteasome unresolved"]},{"year":2001,"claim":"Genetic epistasis defined the division of labor among octamer factors, showing Oct-1 can substitute for Oct-2/OBF-1 in basal Ig transcription while both are required for germinal centers, with OBF-1 most important for IgG.","evidence":"Compound Oct-2/OBF-1 knockout mice, bone marrow reconstitution, flow cytometry","pmids":["11135581"],"confidence":"High","gaps":["Molecular basis of the GC-specific requirement not given"]},{"year":2006,"claim":"Uncovered non-transcriptional functions of OCA-B, identifying a myristoylated membrane isoform that binds and stabilizes the kinase SYK to support pre-BCR/BCR signaling, and an N-terminal interaction with galectin-1 modulating CD45/proliferation.","evidence":"Isoform purification with metabolic myristoylation labeling, fractionation, co-IP, SYK stability and rescue, CD45 phosphatase and proliferation assays","pmids":["11239448","16713566","16565088"],"confidence":"Medium","gaps":["Structural basis of the SYK interaction unresolved","Relative in vivo contribution of nuclear vs membrane isoforms not quantified"]},{"year":2007,"claim":"Placed OCA-B in B-cell transcriptional and oncogenic networks by defining direct targets Spi-B and TNFRSF17/BCMA, and identifying XBP-1(S) as a direct upstream activator of the OCA-B gene during plasma cell differentiation.","evidence":"ChIP, EMSA, microarray, transgenic and knockout mice, siRNA/overexpression with growth assays","pmids":["16861304","17621271","17709512"],"confidence":"Medium","gaps":["Full target-gene network not enumerated","Direct vs indirect myeloma growth dependence incompletely separated"]},{"year":2011,"claim":"Revealed an architectural role: OCA-B at the Igh 3' enhancer interacts with promoter-bound TFII-I to mediate enhancer-promoter looping and relieves HDAC3-mediated repression by competing for TFII-I.","evidence":"Co-IP, in vitro binding, 3C chromosome conformation capture, ChIP, competition assays","pmids":["21549311"],"confidence":"High","gaps":["Generality of looping to non-Igh loci untested here","Dynamics of HDAC3 displacement during activation not resolved"]},{"year":2015,"claim":"Extended OCA-B to T-cell memory, showing it maintains a poised H3K4 chromatin state at memory loci and recruits the demethylase Jmjd1a to Il2/Ifng/Zbtb32 for rapid reactivation.","evidence":"Conditional knockout, ChIP-seq, OCA-B/Jmjd1a co-IP, viral infection model","pmids":["26481684"],"confidence":"High","gaps":["How OCA-B selects memory loci versus naive-cell genes unclear","Direct chromatin-poising mechanism beyond Jmjd1a recruitment not fully defined"]},{"year":2016,"claim":"Defined OCA-B's role in Tfh differentiation by showing it directly transactivates Bcl6 (and Btla) with Oct1/Oct2 in a T-cell-intrinsic manner.","evidence":"ChIP, luciferase reporters, mixed bone marrow chimeras, flow cytometry","pmids":["26957522"],"confidence":"Medium","gaps":["Relationship to the later Bhlhe40-CXCR5 circuit not yet integrated"]},{"year":2019,"claim":"Broadened the T-helper repertoire of OCA-B, showing it enhances RORγt-driven IL-17A in Th17 cells (requiring ternary-complex formation) and synergizes with MTA2/NuRD to repress pre-B genes Igll1/VpreB1.","evidence":"Co-IP, reporter assays, domain mapping, EAE knockout mice, compound knockout genetics with H3K27ac ChIP","pmids":["31103264","31291582"],"confidence":"Medium","gaps":["Direct vs ternary-complex-dependent activation/repression mechanisms not fully separated","Single-lab findings per axis"]},{"year":2021,"claim":"Established OCA-B as a therapeutic target and central GC regulator: it co-occupies GC genes genome-wide with Oct1/Oct2 controlling BCL6/IRF4 balance, and its T-cell loss or peptide inhibition protects NOD mice from autoimmune diabetes; a peripheral adipogenesis role was also reported.","evidence":"ChIP-seq, shRNA, epistasis in GC lymphoma cells; conditional knockout and membrane-penetrating peptide inhibitor pharmacology; adenoviral overexpression in MSCs","pmids":["33512466","33295943","33949290"],"confidence":"High","gaps":["Adipogenesis link is low-confidence with no direct OCA-B-HDAC1 binding shown","Mechanism of peptide inhibitor disruption of complexes not fully detailed"]},{"year":2025,"claim":"Detailed OCA-B's role in pathogenic and migratory T-cell programs, showing it is required for pathogenic maturation of stem-like CD4+ T cells in EAE, drives Tfh CXCR5/GC migration via a Bhlhe40-Pou2af1 axis independent of Bcl6, and restrains Th2 differentiation through indirect association with GATA3.","evidence":"T-cell-specific conditional knockouts, relapsing-remitting EAE, RNA-seq, proximity labeling (BioID), ChIP-seq, recombinant DNA binding, allergy model","pmids":["40299553","41134666","40364837"],"confidence":"Medium","gaps":["Direct vs indirect GATA3 association not biochemically resolved","How one coactivator both activates and restrains lineage programs mechanistically unexplained","Single-lab findings per phenotype"]},{"year":2026,"claim":"Consolidated the recruitment-and-activation model, adding MEF2B as a secondary recruiting factor and the Mediator complex as an activation interface, with GC B-cell-specific inactivation reproducing GC defects.","evidence":"Mechanistic review citing primary data; GC B-cell-specific conditional inactivation","pmids":["41939912"],"confidence":"Medium","gaps":["MEF2B and Mediator contacts not structurally mapped here","Relative weighting of Oct1/2 vs MEF2B recruitment unresolved"]},{"year":null,"claim":"How a single coactivator dynamically partitions between its nuclear octamer-coactivator role and cytoplasmic/membrane signaling functions, and how it switches between gene activation and lineage restriction in different T-helper subsets, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated model linking isoform choice to functional output","Structural basis of MEF2B, Mediator, and SYK interactions undetermined","Determinants of context-dependent activation versus repression unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,4,18,27]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,8,9,31]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[5,21,35]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[11,16]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,8,23,27]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[16]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,21,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,12,23,28]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[21,23,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[16,13]}],"complexes":[],"partners":["POU2F1","POU2F2","SYK","TFII-I","TBP","TAF1C","JMJD1A","SIAH1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16633","full_name":"POU domain class 2-associating factor 1","aliases":["B-cell-specific coactivator OBF-1","BOB-1","OCA-B","OCT-binding factor 1"],"length_aa":256,"mass_kda":27.4,"function":"Transcriptional coactivator that specifically associates with either POU2F1/OCT1 or POU2F2/OCT2 (PubMed:7859290). It boosts the POU2F1/OCT1 mediated promoter activity and to a lesser extent, that of POU2F2/OCT2 (PubMed:7779176). It recognizes the POU domains of POU2F1/OCT1 and POU2F2/OCT2 (PubMed:7779176). It is essential for the response of B-cells to antigens and required for the formation of germinal centers (PubMed:7623806, PubMed:7859290). Regulates IL6 expression in B cells as POU2F2/OCT2 coactivator (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q16633/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POU2AF1","classification":"Not Classified","n_dependent_lines":52,"n_total_lines":1208,"dependency_fraction":0.04304635761589404},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/POU2AF1","total_profiled":1310},"omim":[{"mim_id":"620671","title":"POU CLASS 2 HOMEOBOX-ASSOCIATING FACTOR 2; POU2AF2","url":"https://www.omim.org/entry/620671"},{"mim_id":"615694","title":"POU CLASS 2 HOMEOBOX-ASSOCIATING FACTOR 3; POU2AF3","url":"https://www.omim.org/entry/615694"},{"mim_id":"611767","title":"MICRO RNA 126; MIR126","url":"https://www.omim.org/entry/611767"},{"mim_id":"606221","title":"IKAROS FAMILY ZINC FINGER 3; IKZF3","url":"https://www.omim.org/entry/606221"},{"mim_id":"602894","title":"KILLER CELL LECTIN-LIKE RECEPTOR, SUBFAMILY D, MEMBER 1; KLRD1","url":"https://www.omim.org/entry/602894"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":41.3},{"tissue":"lymphoid tissue","ntpm":111.9},{"tissue":"stomach 1","ntpm":37.8}],"url":"https://www.proteinatlas.org/search/POU2AF1"},"hgnc":{"alias_symbol":["OBF1","BOB1","OCA-B"],"prev_symbol":[]},"alphafold":{"accession":"Q16633","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16633","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16633-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16633-F1-predicted_aligned_error_v6.png","plddt_mean":56.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POU2AF1","jax_strain_url":"https://www.jax.org/strain/search?query=POU2AF1"},"sequence":{"accession":"Q16633","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16633.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16633/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16633"}},"corpus_meta":[{"pmid":"7859290","id":"PMC_7859290","title":"OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins.","date":"1995","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7859290","citation_count":351,"is_preprint":false},{"pmid":"7623806","id":"PMC_7623806","title":"Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7623806","citation_count":245,"is_preprint":false},{"pmid":"8849727","id":"PMC_8849727","title":"B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8849727","citation_count":239,"is_preprint":false},{"pmid":"9096361","id":"PMC_9096361","title":"mcm5/cdc46-bob1 bypasses the requirement for the S phase activator Cdc7p.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9096361","citation_count":222,"is_preprint":false},{"pmid":"8849728","id":"PMC_8849728","title":"The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8849728","citation_count":207,"is_preprint":false},{"pmid":"23045607","id":"PMC_23045607","title":"B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1.","date":"2012","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23045607","citation_count":171,"is_preprint":false},{"pmid":"8654375","id":"PMC_8654375","title":"The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8654375","citation_count":123,"is_preprint":false},{"pmid":"8977324","id":"PMC_8977324","title":"B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1.","date":"1996","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8977324","citation_count":119,"is_preprint":false},{"pmid":"11136971","id":"PMC_11136971","title":"Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11136971","citation_count":118,"is_preprint":false},{"pmid":"11280769","id":"PMC_11280769","title":"Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.","date":"2001","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/11280769","citation_count":109,"is_preprint":false},{"pmid":"11135581","id":"PMC_11135581","title":"B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1.","date":"2001","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11135581","citation_count":88,"is_preprint":false},{"pmid":"9724642","id":"PMC_9724642","title":"OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9724642","citation_count":87,"is_preprint":false},{"pmid":"8769650","id":"PMC_8769650","title":"Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8769650","citation_count":81,"is_preprint":false},{"pmid":"10541551","id":"PMC_10541551","title":"Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10541551","citation_count":78,"is_preprint":false},{"pmid":"11483517","id":"PMC_11483517","title":"The RING finger protein Siah-1 regulates the level of the transcriptional coactivator OBF-1.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11483517","citation_count":69,"is_preprint":false},{"pmid":"9819426","id":"PMC_9819426","title":"Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9819426","citation_count":64,"is_preprint":false},{"pmid":"17621271","id":"PMC_17621271","title":"POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17621271","citation_count":58,"is_preprint":false},{"pmid":"9786883","id":"PMC_9786883","title":"Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-kappaB directs expression of the homing receptor BLR1 to mature B cells.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9786883","citation_count":54,"is_preprint":false},{"pmid":"21549311","id":"PMC_21549311","title":"Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21549311","citation_count":52,"is_preprint":false},{"pmid":"15867091","id":"PMC_15867091","title":"Differential requirement for OBF-1 during antibody-secreting cell differentiation.","date":"2005","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15867091","citation_count":51,"is_preprint":false},{"pmid":"12574333","id":"PMC_12574333","title":"Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12574333","citation_count":51,"is_preprint":false},{"pmid":"14552839","id":"PMC_14552839","title":"OCA-B regulation of B-cell development and function.","date":"2003","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14552839","citation_count":50,"is_preprint":false},{"pmid":"28053195","id":"PMC_28053195","title":"TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1.","date":"2017","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/28053195","citation_count":50,"is_preprint":false},{"pmid":"2674674","id":"PMC_2674674","title":"The OBF1 protein and its DNA-binding site are important for the function of an autonomously replicating sequence in Saccharomyces cerevisiae.","date":"1989","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2674674","citation_count":50,"is_preprint":false},{"pmid":"9832505","id":"PMC_9832505","title":"The Oct-1 POU domain activates snRNA gene transcription by contacting a region in the SNAPc largest subunit that bears sequence similarities to the Oct-1 coactivator OBF-1.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9832505","citation_count":50,"is_preprint":false},{"pmid":"26481684","id":"PMC_26481684","title":"Oct1 and OCA-B are selectively required for CD4 memory T cell function.","date":"2015","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26481684","citation_count":47,"is_preprint":false},{"pmid":"15024018","id":"PMC_15024018","title":"CD86 and beta2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B Expression and binding to the 3'-IgH enhancer in B cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15024018","citation_count":47,"is_preprint":false},{"pmid":"9372961","id":"PMC_9372961","title":"OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9372961","citation_count":46,"is_preprint":false},{"pmid":"26957522","id":"PMC_26957522","title":"The transcriptional coactivator Bob1 promotes the development of follicular T helper cells via Bcl6.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/26957522","citation_count":45,"is_preprint":false},{"pmid":"8618432","id":"PMC_8618432","title":"The B cell transcriptional coactivator BOB1/OBF1 gene fuses to the LAZ3/BCL6 gene by t(3;11)(q27;q23.1) chromosomal translocation in a B cell leukemia line (Karpas 231).","date":"1996","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/8618432","citation_count":43,"is_preprint":false},{"pmid":"8657574","id":"PMC_8657574","title":"Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.","date":"1996","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8657574","citation_count":43,"is_preprint":false},{"pmid":"10329190","id":"PMC_10329190","title":"Oct-1 POU and octamer DNA co-operate to recognise the Bob-1 transcription co-activator via induced folding.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10329190","citation_count":41,"is_preprint":false},{"pmid":"26927796","id":"PMC_26927796","title":"POU2AF1 Functions in the Human Airway Epithelium To Regulate Expression of Host Defense Genes.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26927796","citation_count":40,"is_preprint":false},{"pmid":"9632764","id":"PMC_9632764","title":"Coactivation by OCA-B: definition of critical regions and synergism with general cofactors.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9632764","citation_count":39,"is_preprint":false},{"pmid":"10799892","id":"PMC_10799892","title":"Role of OCA-B in 3'-IgH enhancer function.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10799892","citation_count":38,"is_preprint":false},{"pmid":"16861304","id":"PMC_16861304","title":"The Ets factor Spi-B is a direct critical target of the coactivator OBF-1.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16861304","citation_count":36,"is_preprint":false},{"pmid":"15672409","id":"PMC_15672409","title":"Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia.","date":"2005","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15672409","citation_count":34,"is_preprint":false},{"pmid":"31291582","id":"PMC_31291582","title":"MTA2/NuRD Regulates B Cell Development and Cooperates with OCA-B in Controlling the Pre-B to Immature B Cell Transition.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31291582","citation_count":33,"is_preprint":false},{"pmid":"2034654","id":"PMC_2034654","title":"The multifunctional protein OBF1 is phosphorylated at serine and threonine residues in Saccharomyces cerevisiae.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2034654","citation_count":32,"is_preprint":false},{"pmid":"10604987","id":"PMC_10604987","title":"Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10604987","citation_count":32,"is_preprint":false},{"pmid":"12019222","id":"PMC_12019222","title":"The mcm5-bob1 bypass of Cdc7p/Dbf4p in DNA replication depends on both Cdk1-independent and Cdk1-dependent steps in Saccharomyces cerevisiae.","date":"2002","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12019222","citation_count":31,"is_preprint":false},{"pmid":"11239448","id":"PMC_11239448","title":"Identification and characterization of a novel OCA-B isoform. implications for a role in B cell signaling pathways.","date":"2001","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11239448","citation_count":31,"is_preprint":false},{"pmid":"33512466","id":"PMC_33512466","title":"OBF1 and Oct factors control the germinal center transcriptional program.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33512466","citation_count":30,"is_preprint":false},{"pmid":"2674673","id":"PMC_2674673","title":"Purification and characterization of OBF1: a Saccharomyces cerevisiae protein that binds to autonomously replicating sequences.","date":"1989","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2674673","citation_count":29,"is_preprint":false},{"pmid":"16713566","id":"PMC_16713566","title":"Nontranscriptional regulation of SYK by the coactivator OCA-B is required at multiple stages of B cell development.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713566","citation_count":28,"is_preprint":false},{"pmid":"9442392","id":"PMC_9442392","title":"The B cell-specific coactivator OBF-1 (OCA-B, Bob-1) is inducible in T cells and its expression is dispensable for IL-2 gene induction.","date":"1997","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9442392","citation_count":28,"is_preprint":false},{"pmid":"17709512","id":"PMC_17709512","title":"Identification of ERdj3 and OBF-1/BOB-1/OCA-B as direct targets of XBP-1 during plasma cell differentiation.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17709512","citation_count":26,"is_preprint":false},{"pmid":"16565088","id":"PMC_16565088","title":"Interaction of the B cell-specific transcriptional coactivator OCA-B and galectin-1 and a possible role in regulating BCR-mediated B cell proliferation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16565088","citation_count":26,"is_preprint":false},{"pmid":"24688485","id":"PMC_24688485","title":"Oct2 and Obf1 as Facilitators of B:T Cell Collaboration during a Humoral Immune Response.","date":"2014","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24688485","citation_count":25,"is_preprint":false},{"pmid":"27088119","id":"PMC_27088119","title":"Natalizumab-induced POU2AF1/Spi-B upregulation: A possible route for PML development.","date":"2016","source":"Neurology(R) neuroimmunology & neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/27088119","citation_count":25,"is_preprint":false},{"pmid":"16934875","id":"PMC_16934875","title":"Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.","date":"2006","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/16934875","citation_count":25,"is_preprint":false},{"pmid":"12857960","id":"PMC_12857960","title":"Identification of transcription coactivator OCA-B-dependent genes involved in antigen-dependent B cell differentiation by cDNA array analyses.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12857960","citation_count":24,"is_preprint":false},{"pmid":"11380252","id":"PMC_11380252","title":"Expression of the Oct-1 transcription factor and characterization of its interactions with the Bob1 coactivator.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11380252","citation_count":23,"is_preprint":false},{"pmid":"12727885","id":"PMC_12727885","title":"OBF1 enhances transcriptional potential of Oct1.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12727885","citation_count":21,"is_preprint":false},{"pmid":"10402207","id":"PMC_10402207","title":"Catfish Oct2 binding affinity and functional preference for octamer motifs, and interaction with OBF-1.","date":"1999","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10402207","citation_count":19,"is_preprint":false},{"pmid":"11907094","id":"PMC_11907094","title":"Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11907094","citation_count":18,"is_preprint":false},{"pmid":"33295943","id":"PMC_33295943","title":"Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes.","date":"2021","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33295943","citation_count":17,"is_preprint":false},{"pmid":"16401076","id":"PMC_16401076","title":"Biochemical activities of the BOB1 mutant in Methanobacterium thermoautotrophicum MCM.","date":"2006","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16401076","citation_count":17,"is_preprint":false},{"pmid":"10828057","id":"PMC_10828057","title":"Specific interaction of TAFII105 with OCA-B is involved in activation of octamer-dependent transcription.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10828057","citation_count":17,"is_preprint":false},{"pmid":"10843692","id":"PMC_10843692","title":"Functional analysis of the OCA-B promoter.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10843692","citation_count":17,"is_preprint":false},{"pmid":"18974788","id":"PMC_18974788","title":"Silencing and nuclear repositioning of the lambda5 gene locus at the pre-B cell stage requires Aiolos and OBF-1.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18974788","citation_count":17,"is_preprint":false},{"pmid":"31103264","id":"PMC_31103264","title":"Bob1 enhances RORγt-mediated IL-17A expression in Th17 cells through interaction with RORγt.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31103264","citation_count":15,"is_preprint":false},{"pmid":"19104664","id":"PMC_19104664","title":"Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19104664","citation_count":15,"is_preprint":false},{"pmid":"24217807","id":"PMC_24217807","title":"Germinal center-independent, IgM-mediated autoimmunity in sanroque mice lacking Obf1.","date":"2013","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24217807","citation_count":15,"is_preprint":false},{"pmid":"27080143","id":"PMC_27080143","title":"Bob1 limits cellular frequency of T-follicular helper cells.","date":"2016","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27080143","citation_count":15,"is_preprint":false},{"pmid":"11120805","id":"PMC_11120805","title":"Genetic analyses of NFKB1 and OCA-B function: defects in B cells, serum IgM level, and antibody responses in Nfkb1-/-Oca-b-/- mice.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11120805","citation_count":14,"is_preprint":false},{"pmid":"19224997","id":"PMC_19224997","title":"Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma.","date":"2009","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19224997","citation_count":13,"is_preprint":false},{"pmid":"17562619","id":"PMC_17562619","title":"Primary gastric Hodgkin's lymphoma expressing a B-Cell profile including Oct-2 and Bob-1 proteins.","date":"2007","source":"International journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/17562619","citation_count":13,"is_preprint":false},{"pmid":"27319306","id":"PMC_27319306","title":"Oct2 and Bob1 are sensitive and specific markers in lineage determination of B cell lymphomas with no expression of conventional B cell markers.","date":"2016","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/27319306","citation_count":12,"is_preprint":false},{"pmid":"21905497","id":"PMC_21905497","title":"Evaluation of CARMA1/CARD11 and Bob1 as candidate genes in common variable immunodeficiency.","date":"2011","source":"Journal of investigational allergology & clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21905497","citation_count":11,"is_preprint":false},{"pmid":"27907250","id":"PMC_27907250","title":"The Transcriptional Coactivator Bob1 Is Associated With Pathologic B Cell Responses in Autoimmune Tissue Inflammation.","date":"2017","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/27907250","citation_count":10,"is_preprint":false},{"pmid":"35359635","id":"PMC_35359635","title":"Alterations of the miR-126-3p/POU2AF1/Spi-B Axis and JCPyV Reactivation in Multiple Sclerosis Patients Receiving Natalizumab.","date":"2022","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35359635","citation_count":10,"is_preprint":false},{"pmid":"39128756","id":"PMC_39128756","title":"Structure of POU2AF1 recombinant protein and it affects the progression and treatment of liver cancer based on WGCNA and molecular docking analysis.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39128756","citation_count":10,"is_preprint":false},{"pmid":"11282393","id":"PMC_11282393","title":"The lymphoid-specific cofactor OBF-1 is essential for the expression of a V(H) promoter/HS1,2 enhancer-linked transgene in late B cell development.","date":"2000","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11282393","citation_count":10,"is_preprint":false},{"pmid":"38360857","id":"PMC_38360857","title":"Bob1 maintains T follicular helper cells for long-term humoral immunity.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/38360857","citation_count":9,"is_preprint":false},{"pmid":"8574789","id":"PMC_8574789","title":"Fusion of the LAZ3/BCL6 and BOB1/OBF1 genes by t(3; 11) (q27; q23) chromosomal translocation.","date":"1995","source":"Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie","url":"https://pubmed.ncbi.nlm.nih.gov/8574789","citation_count":9,"is_preprint":false},{"pmid":"28345816","id":"PMC_28345816","title":"Germline variation in the 3'-untranslated region of the POU2AF1 gene is associated with susceptibility to lymphoma.","date":"2017","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/28345816","citation_count":9,"is_preprint":false},{"pmid":"8751468","id":"PMC_8751468","title":"Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease.","date":"1996","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/8751468","citation_count":9,"is_preprint":false},{"pmid":"38386711","id":"PMC_38386711","title":"OCA-B/Pou2af1 is sufficient to promote CD4+ T cell memory and prospectively identifies memory precursors.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/38386711","citation_count":8,"is_preprint":false},{"pmid":"33949290","id":"PMC_33949290","title":"POU2AF1 promotes MSCs adipogenesis by inhibiting HDAC1 expression.","date":"2021","source":"Adipocyte","url":"https://pubmed.ncbi.nlm.nih.gov/33949290","citation_count":8,"is_preprint":false},{"pmid":"30681271","id":"PMC_30681271","title":"Evaluation of SUMO1 and POU2AF1 in whole blood from rheumatoid arthritis patients and at risk relatives.","date":"2019","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/30681271","citation_count":8,"is_preprint":false},{"pmid":"8868069","id":"PMC_8868069","title":"Cloning and characterization of the murine B-cell specific transcriptional coactivator Bob1.","date":"1996","source":"Biological chemistry Hoppe-Seyler","url":"https://pubmed.ncbi.nlm.nih.gov/8868069","citation_count":8,"is_preprint":false},{"pmid":"24719463","id":"PMC_24719463","title":"Cutting edge: The transcription factor Bob1 counteracts B cell activation and regulates miR-146a in B cells.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24719463","citation_count":8,"is_preprint":false},{"pmid":"14662861","id":"PMC_14662861","title":"Critical role for the Oct-2/OCA-B partnership in Ig-secreting cells.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/14662861","citation_count":8,"is_preprint":false},{"pmid":"10330165","id":"PMC_10330165","title":"B-Cell coactivator OBF-1 exhibits unusual transcriptional properties and functions in a DNA-bound Oct-1-dependent fashion.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10330165","citation_count":8,"is_preprint":false},{"pmid":"24061476","id":"PMC_24061476","title":"A C-terminal acidic domain regulates degradation of the transcriptional coactivator Bob1.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24061476","citation_count":7,"is_preprint":false},{"pmid":"14515270","id":"PMC_14515270","title":"The OBF-1 gene locus confers B cell-specific transcription by restricting the ubiquitous activity of its promoter.","date":"2003","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14515270","citation_count":7,"is_preprint":false},{"pmid":"17574818","id":"PMC_17574818","title":"OBF-1 is essential for the generation of antibody-secreting cells and the development of autoimmunity in MRL-lpr mice.","date":"2007","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/17574818","citation_count":7,"is_preprint":false},{"pmid":"35285071","id":"PMC_35285071","title":"OCA-B does not act as a transcriptional coactivator in T cells.","date":"2022","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35285071","citation_count":5,"is_preprint":false},{"pmid":"15796964","id":"PMC_15796964","title":"Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma.","date":"2005","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/15796964","citation_count":5,"is_preprint":false},{"pmid":"11683500","id":"PMC_11683500","title":"Bob1, a Gim5/MM-1/Pfd5 homolog, interacts with the MAP kinase kinase Byr1 to regulate sexual differentiation in the fission yeast, Schizosaccharomyces pombe.","date":"2001","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/11683500","citation_count":4,"is_preprint":false},{"pmid":"40299553","id":"PMC_40299553","title":"OCA-B promotes pathogenic maturation of stem-like CD4+ T cells and autoimmune demyelination.","date":"2025","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/40299553","citation_count":2,"is_preprint":false},{"pmid":"28756244","id":"PMC_28756244","title":"High frequency of Bob1lo T follicular helper cells in florid reactive follicular hyperplasia.","date":"2017","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28756244","citation_count":2,"is_preprint":false},{"pmid":"17346351","id":"PMC_17346351","title":"Bob-1 is expressed in classic Hodgkin lymphoma.","date":"2007","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/17346351","citation_count":2,"is_preprint":false},{"pmid":"12359338","id":"PMC_12359338","title":"Cloning and characterization of the chick Oct binding factor OBF-1.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12359338","citation_count":2,"is_preprint":false},{"pmid":"40364837","id":"PMC_40364837","title":"Transcriptional co-regulator OCA-B/Pou2af1 restricts Th2 differentiation.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/40364837","citation_count":1,"is_preprint":false},{"pmid":"41134666","id":"PMC_41134666","title":"Optimal CXCR5 expression during Tfh maturation involves the Bhlhe40-Pou2af1 axis.","date":"2025","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/41134666","citation_count":1,"is_preprint":false},{"pmid":"38903096","id":"PMC_38903096","title":"Optimal CXCR5 Expression during Tfh Maturation Involves the Bhlhe40-Pou2af1 Axis.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38903096","citation_count":1,"is_preprint":false},{"pmid":"38254723","id":"PMC_38254723","title":"Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.","date":"2024","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38254723","citation_count":1,"is_preprint":false},{"pmid":"41939912","id":"PMC_41939912","title":"Regulation of B cell development and lymphocyte function by transcriptional coactivator OCA-B.","date":"2026","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41939912","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":44998,"output_tokens":8580,"usd":0.131847,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18426,"output_tokens":6511,"usd":0.127452,"stage2_stop_reason":"end_turn"},"total_usd":0.259299,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"OBF-1/OCA-B (POU2AF1) is a B cell-specific transcriptional coactivator with no intrinsic DNA-binding activity that physically associates with the POU domains of Oct-1 and Oct-2 (but not Oct-4 or Oct-6) and stimulates immunoglobulin promoter activity in an octamer site-dependent manner.\",\n      \"method\": \"Yeast two-hybrid screen, biochemical co-association assays, HeLa cell transcription reporter assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — identified by genetic screen then confirmed by biochemical binding and functional transcription assay; independently replicated by two concurrent labs (PMID:7859290 and PMID:7623806)\",\n      \"pmids\": [\"7859290\", \"7623806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"A single OCA-B polypeptide (34–35 kDa) is sufficient for B cell-specific activation of Ig promoters; POU domains of Oct-1 or Oct-2 are sufficient for OCA-B interaction, but an additional Oct activation domain is also required for full functional synergy with OCA-B. OCA-B additionally requires USA-derived general cofactors (including PC2 and PC4) for optimal activity in a reconstituted cell-free system, and directly interacts with PC4.\",\n      \"method\": \"Recombinant protein biochemical reconstitution, in vitro transcription assay, cofactor fractionation and add-back\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted with recombinant protein in cell-free system, multiple orthogonal biochemical methods in one rigorous study\",\n      \"pmids\": [\"7623806\", \"9632764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"OBF-1/OCA-B-deficient mice (generated by gene targeting) show severe defects in antigen-dependent B cell responses and completely fail to develop germinal centers after immunization, while immunoglobulin gene rearrangement/transcription and early B cell development are largely unaffected.\",\n      \"method\": \"Gene targeting / knockout mouse, immunization, histology, serum Ig measurement\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independently replicated in three concurrent knockout mouse studies from different labs\",\n      \"pmids\": [\"8849727\", \"8849728\", \"8977324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"OCA-B binds DNA directly in the major groove between the two POU subdomains, requiring both an adenine at position 5 of the octamer element and contact with the POU domain; an amino-terminal fragment of OCA-B can bind the octamer site independently of a POU domain with the same sequence specificity, suggesting a POU-dependent conformational change exposes the OCA-B N-terminus.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), DNA binding assays with truncation mutants\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct DNA binding established biochemically with multiple truncation mutants, single lab\",\n      \"pmids\": [\"8769650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Bob1/OBF-1 forms ternary complexes with Oct-1 or Oct-2 bound to DNA in a sequence-selective manner; the N-terminal region (amino acids 26–32) of Bob1 contacts the POU-specific subdomain of Oct-1/Oct-2, and ternary complex formation occurs only on a subset of octamer sequences, conferring differential promoter activation.\",\n      \"method\": \"Mutational analysis, EMSA ternary complex assays, transcription reporter assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with EMSA and functional transcription assay in one study; findings consistent with multiple other structural and biochemical studies\",\n      \"pmids\": [\"8654375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"OCA-B makes selective contacts with both the POU-specific domain (residues L6, E7) and the POU homeodomain (residues K155, I159) of Oct-1, acting as a molecular clamp that holds together the two moieties of the POU domain on DNA; in vivo, OCA-B can recruit two artificially separated POU domain halves to a promoter to achieve transactivation.\",\n      \"method\": \"Oct-1/Pit-1 POU domain chimeras, alanine-scanning mutagenesis, methylation interference, phosphorothioate EMSA, in vivo transactivation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biochemical methods plus in vivo functional validation, single lab\",\n      \"pmids\": [\"9819426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"OCA-B is a functional analog of VP16 in that it provides a transcriptional activation domain and stabilizes Oct-1 on the octamer sequence, but contacts a different surface of the Oct-1 POU domain (both POU-specific and POU homeodomain plus center of octamer DNA); OCA-B and VP16 can bind the Oct-1 POU domain simultaneously.\",\n      \"method\": \"In vitro binding assays, transcription reporter assays, competition binding experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical and functional assays, single lab\",\n      \"pmids\": [\"9372961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"OBF-1 interacts with the general transcription factors TBP and TFIIB in the absence of DNA, in addition to its interactions with Oct-1/Oct-2 POU domains. OBF-1 activates promoter octamer sites but not enhancer octamer sites.\",\n      \"method\": \"In vitro protein interaction assay, transcription reporter assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-interaction assay plus functional reporter, single lab\",\n      \"pmids\": [\"8657574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Crystal structure (3.2 Å) of OCA-B peptide/Oct-1 POU domain/octamer DNA ternary complex shows: OCA-B peptide binds in the major groove near the center of the octamer, forming hydrogen bonds with adenine at position 5; an alpha-helix of OCA-B binds a hydrophobic pocket on the POU-specific domain; both peptide-DNA and peptide-protein contacts provide structural specificity.\",\n      \"method\": \"X-ray crystallography (3.2 Å resolution)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure at 3.2 Å, consistent with prior biochemical studies, directly establishes molecular contacts\",\n      \"pmids\": [\"10541551\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Bob1 binds specifically as a monomer to the complex of Oct-1 POU domain and Igκ promoter DNA, but binds weakly to either component alone, indicating both are required for avid binding; ternary complex formation requires defined DNA sequence and is sensitive to single base-pair changes; Bob1 undergoes partial folding upon ternary complex formation (induced folding).\",\n      \"method\": \"Biophysical characterization (gel filtration, calorimetry, circular dichroism, ITC)\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biophysical methods establishing mechanism of ternary complex assembly, single lab\",\n      \"pmids\": [\"10329190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The POU dimer assembled on the PORE sequence (ATTTGAAATGCAAAT) can recruit OBF-1, whereas POU dimers formed on the MORE sequence cannot interact with OBF-1 because the same Oct-1 residues that form the MORE dimerization interface are also used for OBF-1/Oct-1 interactions on the PORE. Thus specific POU dimer configurations differentially recruit OBF-1.\",\n      \"method\": \"EMSA ternary complex formation assays, dimerization interface mutagenesis, transcription reporter assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with EMSA and functional transcription assay, single lab but rigorous mechanistic resolution\",\n      \"pmids\": [\"11136971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The RING finger E3 ubiquitin ligase Siah-1 directly interacts with OBF-1 (via Siah-1 C-terminus and OBF-1 N-terminus, partly distinct from the Oct/DNA interaction surface); this interaction leads to downregulation of OBF-1 protein level (not mRNA) and reduction in octamer-dependent transcription; inhibition of the ubiquitin-proteasome pathway in B cells elevates OBF-1 protein; OBF-1 protein dramatically increases in primary activated B cells upon immunization without change in mRNA.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, protein level analysis, proteasome inhibitor treatment, in vivo B cell activation experiments\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal interaction mapping, proteasome inhibitor experiments, and in vivo validation, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"11483517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mice whose lymphoid compartment is reconstituted with cells lacking both Oct-2 and OBF-1 still develop B cells to the IgM+ stage with essentially unaffected Ig gene transcription, implying that ubiquitous Oct-1 can substitute for Oct-2 and OBF-1 in basic Ig transcription; both factors are essential for germinal center formation, with OBF-1 being more important for IgG production.\",\n      \"method\": \"Genetic epistasis via compound knockout mice, bone marrow reconstitution, flow cytometry, Ig transcription analysis\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-knockout epistasis with defined B cell phenotype, replicated across multiple labs\",\n      \"pmids\": [\"11135581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"OCA-B has a novel membrane-associated isoform (p35/p40) that is myristoylated in vivo; myristoylation leads to localization of p35 to membrane compartments, distinct from the nuclear p34 isoform, suggesting a non-transcriptional signaling function in late B cell development.\",\n      \"method\": \"Biochemical purification, metabolic labeling for myristoylation, subcellular fractionation, isoform characterization\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct biochemical demonstration of myristoylation and membrane localization, single lab\",\n      \"pmids\": [\"11239448\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TAF(II)105 (a B cell-enriched TFIID subunit) specifically interacts with the C-terminal activation domain of OCA-B and is required for OCA-B-dependent octamer-mediated transcription in B cells; this interaction links TFIID to B cell-specific transcription.\",\n      \"method\": \"In vitro binding assays, dominant-negative overexpression, antibody inhibition of transcription, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction mapping, functional inhibition, reporter assay; single lab\",\n      \"pmids\": [\"10828057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"OBF1 stabilizes POU dimer–DNA interactions on PORE-type sequences and overrides Oct1 interface mutations that would otherwise abolish PORE-mediated dimerization; the PORE-type Oct1/Oct2 dimer (not the monomer) is the primary target of OBF1, and OBF1 alleviates DNA sequence requirements of the Oct1 dimer on PORE-related sequences.\",\n      \"method\": \"EMSA, in vitro ternary complex formation with mutant POU proteins, transcription reporter assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical assays clarifying dimer vs monomer targeting, single lab\",\n      \"pmids\": [\"12727885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"OCA-B directly interacts with the tyrosine kinase SYK in the cytoplasm and directly regulates SYK protein stability; this non-transcriptional function is required for pre-BCR and BCR signaling at multiple stages of B cell development (pre-B1 to pre-B2 transition).\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, SYK stability assays, genetic rescue experiments\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP of endogenous proteins, stability assays, cytoplasmic localization, defined developmental phenotype; single lab but rigorous multi-method study\",\n      \"pmids\": [\"16713566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"OCA-B directly interacts with galectin-1 (and related galectins) via its N-terminal domain; in OCA-B-deficient B cells, increased galectin-1 expression and cell surface association correlates with reduced CD45 phosphatase activity and negative regulation of B cell proliferation upon BCR stimulation.\",\n      \"method\": \"Co-immunoprecipitation (in vivo and in vitro), domain mapping, CD45 phosphatase activity assay, B cell proliferation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP and in vitro binding with domain mapping, single lab\",\n      \"pmids\": [\"16565088\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"The Ets transcription factor Spi-B is a direct transcriptional target of OBF-1; OBF-1 binds to the Spi-B promoter and OBF-1 deficiency reduces Spi-B expression; transgenic T cell expression of OBF-1 reveals Spi-B as a critical downstream mediator linking OBF-1 to B cell receptor signaling and germinal center formation.\",\n      \"method\": \"Transgenic mouse overexpression, microarray analysis, chromatin immunoprecipitation (ChIP), knockout mouse experiments\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus microarray plus genetic gain- and loss-of-function in vivo, single lab\",\n      \"pmids\": [\"16861304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"XBP-1(S) directly binds to the OBF-1/BOB-1/OCA-B promoter (at a UPR element conserved in mouse and human) in plasmacytoma cells and in primary B cells, both during plasma cell differentiation and in response to UPR activation, identifying OCA-B as a direct transcriptional target of XBP-1(S).\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), gel shift assay (EMSA), shRNA knockdown, promoter-reporter assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus EMSA plus shRNA with functional readout, single lab\",\n      \"pmids\": [\"17709512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"POU2AF1/OCA-B directly binds to an octamer site within the 5' regulatory region of TNFRSF17 (BCMA) and transactivates its expression; knockdown of POU2AF1 by siRNA inhibits multiple myeloma cell growth, while ectopic expression promotes it.\",\n      \"method\": \"siRNA knockdown, ectopic overexpression, ChIP, promoter reporter assay, cell growth assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct binding plus functional siRNA/overexpression with cellular phenotype, single lab\",\n      \"pmids\": [\"17621271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"OCA-B directly interacts with transcription factor TFII-I; OCA-B bound to the Igh 3' enhancer interacts with promoter-bound TFII-I to mediate promoter-enhancer looping (in cis and trans), and OCA-B also relieves HDAC3-mediated Igh promoter repression by competing with HDAC3 for binding to TFII-I.\",\n      \"method\": \"Co-immunoprecipitation, chromatin conformation capture (3C), ChIP, in vitro binding assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction by co-IP and in vitro binding, chromosome conformation capture for looping, competition assay for HDAC3 displacement; multiple orthogonal methods, single lab\",\n      \"pmids\": [\"21549311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Bob1 protein degradation is proteasome-mediated but does not require ubiquitination of Bob1; a C-terminal acidic region of Bob1 regulates the activity of degron signals elsewhere in the protein; tyrosine phosphorylation-mimetic mutations that make the C terminus more acidic stabilize the Bob1 protein, suggesting signaling pathways regulate Bob1 stability through this mechanism. Expression of a stable Bob1 mutant in B cells suppresses cell proliferation and induces differentiation markers.\",\n      \"method\": \"Fluorescent protein reporter degradation assay, proteasome inhibitor treatment, mutagenesis (phosphomimetic substitutions), ubiquitination assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional mutagenesis experiments and proteasome inhibitors, single lab\",\n      \"pmids\": [\"24061476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"OCA-B is required for CD4+ T cell memory: it is needed to maintain a poised (H3K4me1/H3K4me3) chromatin state at the Il2 locus in resting previously stimulated CD4+ T cells, and recruits the histone lysine demethylase Jmjd1a to target loci including Il2, Ifng, and Zbtb32, enabling rapid gene reactivation upon antigen re-encounter.\",\n      \"method\": \"Conditional knockout mice, ChIP-seq, co-immunoprecipitation (OCA-B with Jmjd1a), flow cytometry, in vivo viral infection model\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-seq, co-IP of endogenous proteins, conditional KO with defined memory phenotype, and mechanistic histone demethylase recruitment; multiple orthogonal methods\",\n      \"pmids\": [\"26481684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Bob1 (OBF1) directly binds to and transactivates the Bcl6 and Btla promoters in CD4+ T cells together with Oct1/Oct2; mixed bone marrow chimeras demonstrated this is a T cell-intrinsic requirement for Bcl6 expression and Tfh cell development/pool size.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), luciferase reporter assay, mixed bone marrow chimeras, flow cytometry\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter plus in vivo chimera, single lab\",\n      \"pmids\": [\"26957522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bob1 interacts with RORγt (via the ligand-binding domain of RORγt) and enhances RORγt-mediated IL-17A transcription in Th17 cells; this enhancement requires the ability of Bob1 to form a DNA-Oct1-Bob1 ternary complex.\",\n      \"method\": \"Co-immunoprecipitation, reporter gene assay, Bob1 knockout mice (EAE model), domain mapping\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus functional reporter plus in vivo KO, single lab\",\n      \"pmids\": [\"31103264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MTA2/NuRD complex and OCA-B synergistically repress Igll1 and VpreB1 at the pre-B cell stage; MTA2 deficiency leads to increased H3K27 acetylation at these promoters; OCA-B and MTA2 cooperate to regulate the pre-B to immature B cell transition.\",\n      \"method\": \"Compound knockout mouse genetics, ChIP (H3K27ac), gene expression profiling\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — compound genetic epistasis plus ChIP, single lab\",\n      \"pmids\": [\"31291582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"OBF1, OCT1, and OCT2 colocalize genome-wide (ChIP-seq) at promoters and enhancers of GC regulatory genes (BCL6, IRF4, etc.) in GC B cells; OBF1 downregulation (shRNA) disrupts the GC transcriptional program: GC maintenance genes (e.g., BCL6) are downregulated and GC exit genes (e.g., IRF4) are upregulated; ectopic BCL6 does not rescue proliferation of OBF1-depleted GC lymphoma cells unless IRF4 is also depleted.\",\n      \"method\": \"ChIP-seq, shRNA knockdown, ectopic expression, cell proliferation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq plus functional shRNA with epistasis experiment, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"33512466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"T cell-specific conditional OCA-B knockout protects NOD mice from spontaneous autoimmune diabetes; rationally designed membrane-penetrating OCA-B peptide inhibitors normalized blood glucose and reduced T cell infiltration and proinflammatory cytokine expression in newly diabetic NOD mice, demonstrating pharmacologic inhibitability.\",\n      \"method\": \"Conditional knockout mouse (Cre-lox), peptide inhibitor pharmacology, histology, flow cytometry, cytokine measurement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined phenotype plus peptide inhibitor with functional readout, single lab, multiple approaches\",\n      \"pmids\": [\"33295943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"POU2AF1/OCA-B promotes MSC adipogenesis by inhibiting nuclear translocation and mRNA expression of HDAC1; overexpression of OCA-B promoted spontaneous adipogenesis, and co-transfection with HDAC1 partially reversed this effect.\",\n      \"method\": \"Adenoviral overexpression, siRNA knockdown, Oil-red O staining, Western blot, subcellular fractionation\",\n      \"journal\": \"Adipocyte\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single cell type, no direct binding demonstrated between OCA-B and HDAC1\",\n      \"pmids\": [\"33949290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"OCA-B expression is sufficient to improve CD4+ T cell antiviral memory recall responses; high endogenous OCA-B expression early in viral infection prospectively identifies memory precursor cells with increased survival and memory recall potential (using OCA-B mCherry reporter mouse).\",\n      \"method\": \"Ectopic overexpression in vivo (retroviral), OCA-B-mCherry reporter mouse, viral infection model, flow cytometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function in vivo plus reporter mouse, single lab, multiple functional assays\",\n      \"pmids\": [\"38386711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"EMSA-SELEX-Seq analysis reaffirms that BOB1 selectively engages the dimer configuration of OCT1/2, but clarifies that monomeric OCT1/2 assembled on the classical octamer ATGCAAAT and related motifs are also primary BOB1 targets; BOB1 imposes a specific DNA sequence preference on OCT1/2 in monomeric configuration.\",\n      \"method\": \"EMSA-SELEX-Seq (in vitro selection combined with sequencing)\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous in vitro binding/selection method, but single study refining/contradicting prior model\",\n      \"pmids\": [\"38254723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"OCA-B is required for pathogenic maturation of stem-like CD4+ T cells in EAE; T cell-intrinsic OCA-B loss nearly eliminates CNS infiltration and clinical disease upon autoantigen re-encounter; OCA-B promotes Tcf7, Slamf6, and Sell expression in proliferating CNS T cell populations during remission, and its loss at relapse results in accumulation of immunomodulatory (Ccr9+Bach2+) CD4+ T cells.\",\n      \"method\": \"T cell-specific conditional knockout (Cre-lox), relapsing-remitting EAE model, flow cytometry, gene expression analysis\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined in vivo phenotype, single lab\",\n      \"pmids\": [\"40299553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Pou2af1/OCA-B in Tfh cells promotes optimal CXCR5 expression and GC migration through a Bhlhe40-Pou2af1 axis: Pou2af1 upregulates CXCR5 but not Bcl6, while Bhlhe40 represses Pou2af1 expression; this circuit operates independently of the Bcl6-Blimp1 fate-determination axis.\",\n      \"method\": \"Conditional knockout, RNA-seq of antigen-specific Tfh cells, flow cytometry, CXCR5 expression analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with RNA-seq and defined phenotype, single lab\",\n      \"pmids\": [\"41134666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"OCA-B restricts Th2 differentiation: proximity labeling shows OCA-B indirectly associates with GATA3; ChIP-seq reveals co-enrichment of GATA3 and Oct1 (OCA-B partner) at the Th2 locus control region (Il4, Il13, Il5, Gata3, Irf4); recombinant protein DNA binding and reporter assays are consistent with OCA-B restraining transcription at these loci.\",\n      \"method\": \"Proximity labeling (BioID), ChIP-seq, recombinant protein DNA binding assay, reporter assay, in vivo papain allergy model with T cell-specific OCA-B deletion\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods including ChIP-seq, biochemical binding, and in vivo conditional KO, single lab\",\n      \"pmids\": [\"40364837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"OCA-B is recruited to target genes through primary interactions with DNA-binding transcription factors OCT1/OCT2 as well as secondary interactions with MEF2B; its transcriptional activation involves interactions with the Mediator coactivator complex; GC B cell-specific inactivation of Oca-B is sufficient to cause GC defects.\",\n      \"method\": \"Mechanistic review citing primary experimental data; GC B cell-specific conditional inactivation\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — review citing primary experimental evidence for MEF2B interaction and Mediator complex interaction; conditional GC B cell KO\",\n      \"pmids\": [\"41939912\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POU2AF1/OCA-B/OBF-1/Bob1 is a lymphoid-enriched transcriptional coactivator that lacks intrinsic DNA-binding activity but is recruited to octamer-containing promoters and enhancers by forming a ternary complex with DNA-bound Oct-1 or Oct-2 (contacting both POU-specific and POU homeodomain subdomains as well as the DNA major groove); it activates Ig and other B cell target genes by engaging general cofactors (TBP, TFIIB, PC4, PC2, TAF(II)105) and the Mediator complex, mediates Igh enhancer-promoter looping via direct interaction with TFII-I, and has its protein level controlled by Siah-1/proteasome-mediated degradation regulated by a C-terminal acidic degron; beyond its nuclear transcriptional role, a myristoylated membrane-bound isoform (p35) directly interacts with the tyrosine kinase SYK in the cytoplasm to regulate BCR/pre-BCR signaling and B cell survival; in T cells, OCA-B recruits the histone demethylase Jmjd1a to maintain chromatin poising at memory-associated loci (Il2, Ifng), promotes Tfh development by transactivating Bcl6 and CXCR5, and drives pathogenic autoreactive CD4+ T cell responses, making it an essential regulator of germinal center formation, humoral immunity, and multiple autoimmune processes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POU2AF1 (OCA-B/OBF-1/Bob1) is a lymphoid-restricted transcriptional coactivator that lacks intrinsic sequence-specific DNA-binding activity and instead acts by docking onto DNA-bound octamer-binding factors Oct-1 and Oct-2 to drive immunoglobulin and other B-cell target genes [#0, #1]. Structural and biophysical work shows it assembles a ternary complex in which an OCA-B peptide inserts into the octamer major groove, contacting an adenine at position 5, while an OCA-B \\u03b1-helix engages a hydrophobic pocket on the POU-specific subdomain; OCA-B further clamps the POU-specific and POU homeodomain halves together on DNA and undergoes induced folding upon complex assembly [#5, #8, #9]. Octamer recognition is configuration-selective: OCA-B is stabilized on monomeric octamer sites and on PORE-type Oct dimers but is excluded from MORE-type dimers whose interface overlaps the OCA-B contact surface [#10, #31]. Once recruited, OCA-B transactivates by engaging the general transcription machinery and B-cell-enriched cofactors\\u2014TBP and TFIIB, the USA cofactors PC2/PC4, and the TFIID subunit TAF(II)105\\u2014and mediates Igh enhancer-promoter looping through direct interaction with TFII-I while displacing repressive HDAC3 [#1, #7, #14, #21]. In vivo, OCA-B is dispensable for early B-cell development and basal Ig transcription but is essential for antigen-dependent germinal center formation and the germinal-center transcriptional program (BCL6 up, IRF4 restrained) [#2, #12, #27]. Its abundance is set post-translationally by Siah-1/proteasome-dependent turnover acting through a C-terminal acidic degron, linking signaling to coactivator dosage [#11, #22]. Beyond the nucleus, a myristoylated membrane isoform directly binds the tyrosine kinase SYK to stabilize it and support pre-BCR/BCR signaling during B-cell development [#13, #16]. In T cells, OCA-B partners with Oct1/Oct2 and recruits the demethylase Jmjd1a to poise memory loci (Il2, Ifng), drives Tfh development via Bcl6/CXCR5, and licenses pathogenic autoreactive CD4+ responses, establishing it as a tractable target whose inhibition protects against autoimmune diabetes and EAE [#23, #24, #28, #32, #33].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established the founding mechanistic principle: OCA-B is a B-cell-specific coactivator with no intrinsic DNA binding that works by associating with the POU domains of Oct-1/Oct-2 to activate octamer-dependent Ig transcription.\",\n      \"evidence\": \"Yeast two-hybrid screen, co-association assays, and reconstituted in vitro transcription with recombinant protein and cofactor add-back\",\n      \"pmids\": [\"7859290\", \"7623806\", \"9632764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the atomic contacts with the POU domain\", \"Required general cofactors (PC2/PC4) identified but mechanism of their contribution unresolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Genetic loss-of-function pinned OCA-B's physiological role to antigen-dependent humoral immunity rather than basal Ig expression, by showing knockouts fail to form germinal centers while early B development and Ig rearrangement are intact.\",\n      \"evidence\": \"Three concurrent gene-targeted knockout mouse studies with immunization and histology\",\n      \"pmids\": [\"8849727\", \"8849728\", \"8977324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain why basal Ig transcription is spared\", \"Downstream target genes mediating the GC defect not identified\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Resolved how a DNA-binding-deficient coactivator gains octamer selectivity, showing OCA-B contacts the DNA major groove (requiring adenine at octamer position 5) and the POU-specific subdomain, forming ternary complexes only on a subset of octamer sequences.\",\n      \"evidence\": \"EMSA ternary complex assays, truncation/point mutagenesis, transcription reporters\",\n      \"pmids\": [\"8769650\", \"8654375\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution geometry not yet determined\", \"Functional consequence of sequence-selective recruitment in vivo unaddressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Defined the dual-contact 'molecular clamp' mechanism in which OCA-B simultaneously grips the POU-specific and POU homeodomain subdomains and bridges separated POU halves on a promoter.\",\n      \"evidence\": \"POU domain chimeras, alanine scanning, methylation/phosphorothioate interference, in vivo transactivation\",\n      \"pmids\": [\"9819426\", \"8657574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Connection to general transcription machinery recruitment incompletely mapped\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Provided the structural and thermodynamic basis of complex assembly, visualizing OCA-B peptide-DNA and peptide-protein contacts and demonstrating cooperative, induced-folding ternary binding.\",\n      \"evidence\": \"3.2 \\u00c5 X-ray crystal structure plus gel filtration, calorimetry, CD, ITC\",\n      \"pmids\": [\"10541551\", \"10329190\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystallized peptide rather than full-length protein\", \"Structure of OCA-B engaging Oct dimers not captured\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Clarified which Oct configuration OCA-B preferentially targets, showing OCA-B stabilizes PORE-type Oct1/Oct2 dimers and overrides interface mutations, but cannot engage MORE-type dimers due to overlapping surfaces.\",\n      \"evidence\": \"EMSA ternary complex with mutant POU proteins and transcription reporters\",\n      \"pmids\": [\"11136971\", \"12727885\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide proportion of monomer vs dimer targets unresolved at the time\", \"Promoter-context determinants of dimer formation incompletely defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Refined the DNA recognition model using unbiased selection, confirming dimer engagement but re-establishing monomeric Oct1/2 on classical octamers as primary OCA-B targets and showing OCA-B imposes its own sequence preference.\",\n      \"evidence\": \"EMSA-SELEX-Seq in vitro selection\",\n      \"pmids\": [\"38254723\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study refining the prior dimer-centric model\", \"In vivo correlation with occupancy not addressed in the same work\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Connected OCA-B to the basal transcription apparatus by identifying the B-cell-enriched TFIID subunit TAF(II)105 as a C-terminal activation-domain partner required for octamer transcription.\",\n      \"evidence\": \"In vitro binding, dominant-negative and antibody inhibition, reporter assays\",\n      \"pmids\": [\"10828057\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry within TFIID not defined\", \"Relative contribution of TAF(II)105 versus TBP/TFIIB unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed OCA-B abundance is controlled post-translationally, identifying Siah-1-mediated proteasomal degradation as a switch that rises sharply upon B-cell activation independent of mRNA.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal co-IP, proteasome inhibitor and in vivo activation experiments\",\n      \"pmids\": [\"11483517\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Siah-1 directly ubiquitinates OCA-B not settled here\", \"Upstream signals controlling Siah-1 engagement unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Refined the degradation mechanism, showing proteasomal turnover proceeds without OCA-B ubiquitination and is gated by a C-terminal acidic degron whose acidity (mimicking tyrosine phosphorylation) stabilizes the protein.\",\n      \"evidence\": \"Fluorescent reporter degradation assays, phosphomimetic mutagenesis, proteasome inhibitors, ubiquitination assay\",\n      \"pmids\": [\"24061476\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the kinase generating the stabilizing modification not established\", \"How a ubiquitin-independent substrate is delivered to the proteasome unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetic epistasis defined the division of labor among octamer factors, showing Oct-1 can substitute for Oct-2/OBF-1 in basal Ig transcription while both are required for germinal centers, with OBF-1 most important for IgG.\",\n      \"evidence\": \"Compound Oct-2/OBF-1 knockout mice, bone marrow reconstitution, flow cytometry\",\n      \"pmids\": [\"11135581\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the GC-specific requirement not given\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Uncovered non-transcriptional functions of OCA-B, identifying a myristoylated membrane isoform that binds and stabilizes the kinase SYK to support pre-BCR/BCR signaling, and an N-terminal interaction with galectin-1 modulating CD45/proliferation.\",\n      \"evidence\": \"Isoform purification with metabolic myristoylation labeling, fractionation, co-IP, SYK stability and rescue, CD45 phosphatase and proliferation assays\",\n      \"pmids\": [\"11239448\", \"16713566\", \"16565088\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the SYK interaction unresolved\", \"Relative in vivo contribution of nuclear vs membrane isoforms not quantified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed OCA-B in B-cell transcriptional and oncogenic networks by defining direct targets Spi-B and TNFRSF17/BCMA, and identifying XBP-1(S) as a direct upstream activator of the OCA-B gene during plasma cell differentiation.\",\n      \"evidence\": \"ChIP, EMSA, microarray, transgenic and knockout mice, siRNA/overexpression with growth assays\",\n      \"pmids\": [\"16861304\", \"17621271\", \"17709512\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Full target-gene network not enumerated\", \"Direct vs indirect myeloma growth dependence incompletely separated\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed an architectural role: OCA-B at the Igh 3' enhancer interacts with promoter-bound TFII-I to mediate enhancer-promoter looping and relieves HDAC3-mediated repression by competing for TFII-I.\",\n      \"evidence\": \"Co-IP, in vitro binding, 3C chromosome conformation capture, ChIP, competition assays\",\n      \"pmids\": [\"21549311\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of looping to non-Igh loci untested here\", \"Dynamics of HDAC3 displacement during activation not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extended OCA-B to T-cell memory, showing it maintains a poised H3K4 chromatin state at memory loci and recruits the demethylase Jmjd1a to Il2/Ifng/Zbtb32 for rapid reactivation.\",\n      \"evidence\": \"Conditional knockout, ChIP-seq, OCA-B/Jmjd1a co-IP, viral infection model\",\n      \"pmids\": [\"26481684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How OCA-B selects memory loci versus naive-cell genes unclear\", \"Direct chromatin-poising mechanism beyond Jmjd1a recruitment not fully defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined OCA-B's role in Tfh differentiation by showing it directly transactivates Bcl6 (and Btla) with Oct1/Oct2 in a T-cell-intrinsic manner.\",\n      \"evidence\": \"ChIP, luciferase reporters, mixed bone marrow chimeras, flow cytometry\",\n      \"pmids\": [\"26957522\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship to the later Bhlhe40-CXCR5 circuit not yet integrated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Broadened the T-helper repertoire of OCA-B, showing it enhances RORγt-driven IL-17A in Th17 cells (requiring ternary-complex formation) and synergizes with MTA2/NuRD to repress pre-B genes Igll1/VpreB1.\",\n      \"evidence\": \"Co-IP, reporter assays, domain mapping, EAE knockout mice, compound knockout genetics with H3K27ac ChIP\",\n      \"pmids\": [\"31103264\", \"31291582\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs ternary-complex-dependent activation/repression mechanisms not fully separated\", \"Single-lab findings per axis\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established OCA-B as a therapeutic target and central GC regulator: it co-occupies GC genes genome-wide with Oct1/Oct2 controlling BCL6/IRF4 balance, and its T-cell loss or peptide inhibition protects NOD mice from autoimmune diabetes; a peripheral adipogenesis role was also reported.\",\n      \"evidence\": \"ChIP-seq, shRNA, epistasis in GC lymphoma cells; conditional knockout and membrane-penetrating peptide inhibitor pharmacology; adenoviral overexpression in MSCs\",\n      \"pmids\": [\"33512466\", \"33295943\", \"33949290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Adipogenesis link is low-confidence with no direct OCA-B-HDAC1 binding shown\", \"Mechanism of peptide inhibitor disruption of complexes not fully detailed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Detailed OCA-B's role in pathogenic and migratory T-cell programs, showing it is required for pathogenic maturation of stem-like CD4+ T cells in EAE, drives Tfh CXCR5/GC migration via a Bhlhe40-Pou2af1 axis independent of Bcl6, and restrains Th2 differentiation through indirect association with GATA3.\",\n      \"evidence\": \"T-cell-specific conditional knockouts, relapsing-remitting EAE, RNA-seq, proximity labeling (BioID), ChIP-seq, recombinant DNA binding, allergy model\",\n      \"pmids\": [\"40299553\", \"41134666\", \"40364837\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect GATA3 association not biochemically resolved\", \"How one coactivator both activates and restrains lineage programs mechanistically unexplained\", \"Single-lab findings per phenotype\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Consolidated the recruitment-and-activation model, adding MEF2B as a secondary recruiting factor and the Mediator complex as an activation interface, with GC B-cell-specific inactivation reproducing GC defects.\",\n      \"evidence\": \"Mechanistic review citing primary data; GC B-cell-specific conditional inactivation\",\n      \"pmids\": [\"41939912\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MEF2B and Mediator contacts not structurally mapped here\", \"Relative weighting of Oct1/2 vs MEF2B recruitment unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single coactivator dynamically partitions between its nuclear octamer-coactivator role and cytoplasmic/membrane signaling functions, and how it switches between gene activation and lineage restriction in different T-helper subsets, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated model linking isoform choice to functional output\", \"Structural basis of MEF2B, Mediator, and SYK interactions undetermined\", \"Determinants of context-dependent activation versus repression unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 4, 18, 27]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 8, 9, 31]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [5, 21, 35]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [11, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 8, 23, 27]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 21, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 12, 23, 28]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [21, 23, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [16, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"POU2F1\", \"POU2F2\", \"SYK\", \"TFII-I\", \"TBP\", \"TAF1C\", \"JMJD1A\", \"SIAH1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}